{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:31:05Z","timestamp":1793691065408,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5048-4","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T07:39:46Z","timestamp":1543909186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-740X","authenticated-orcid":false,"given":"Carlos","family":"Fortea-Sanchis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mart\u00ednez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escrig-Sos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"15","key":"5048_CR1","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ejca.2015.07.024","volume":"51","author":"B Holleczek","year":"2015","unstructured":"Holleczek B, Rossi S, Domenic A, et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - results from the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2158\u201368. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2015.07.024\n                    \n                  .","journal-title":"Eur J Cancer"},{"issue":"22","key":"5048_CR2","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1200\/JCO.2006.06.8866","volume":"24","author":"PM Johnson","year":"2006","unstructured":"Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24(22):3570\u20135. \n                    https:\/\/doi.org\/10.1200\/JCO.2006.06.8866\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"1","key":"5048_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","volume":"10","author":"RS Swanson","year":"2003","unstructured":"Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol Off J Soc Surg Oncol. 2003;10(1):65\u201371. \n                    https:\/\/doi.org\/10.1245\/ASO.2003.03.058\n                    \n                  .","journal-title":"Ann Surg Oncol Off J Soc Surg Oncol"},{"issue":"15","key":"5048_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1200\/JCO.2003.05.062","volume":"21","author":"TE Le Voyer","year":"2003","unstructured":"Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21(15):2912\u20139. \n                    https:\/\/doi.org\/10.1200\/JCO.2003.05.062\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"5048_CR5","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1177\/0962280215601873","volume":"26","author":"I Barrio","year":"2017","unstructured":"Barrio I, Arostegui I, Rodr\u00edguez-\u00c1lvarez MX, Quintana JM. A new approach to categorising continuous variables in prediction models: proposal and validation. Stat Methods Med Res. 2017;26:2586\u2013602. \n                    https:\/\/doi.org\/10.1177\/0962280215601873\n                    \n                  .","journal-title":"Stat Methods Med Res"},{"issue":"11","key":"5048_CR6","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1245\/s10434-010-1158-1","volume":"17","author":"W Ceelen","year":"2010","unstructured":"Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17(11):2847\u201355. \n                    https:\/\/doi.org\/10.1245\/s10434-010-1158-1\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"5048_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00384-014-1848-4","volume":"29","author":"SJ Moug","year":"2014","unstructured":"Moug SJ, Oliphant R, Balsitis M, Molloy RG, Morrison DS. The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy. Int J Color Dis. 2014;29(5):599\u2013604. \n                    https:\/\/doi.org\/10.1007\/s00384-014-1848-4\n                    \n                  .","journal-title":"Int J Color Dis"},{"issue":"12","key":"5048_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cgh.2006.07.016","volume":"4","author":"R Ricciardi","year":"2006","unstructured":"Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-based analyses of lymph node metastases in colorectal Cancer. Clin Gastroenterol Hepatol. 2006;4(12):1522\u20137. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2006.07.016\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5048_CR9","doi-asserted-by":"publisher","unstructured":"Vinh-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res. 2004;6(6). \n                    https:\/\/doi.org\/10.1186\/bcr934\n                    \n                  .","DOI":"10.1186\/bcr934"},{"issue":"2","key":"5048_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00268-006-0487-5","volume":"31","author":"E Yildirim","year":"2007","unstructured":"Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg. 2007;31(2):276\u201389. \n                    https:\/\/doi.org\/10.1007\/s00268-006-0487-5\n                    \n                  .","journal-title":"World J Surg"},{"issue":"11","key":"5048_CR11","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/cncr.24989","volume":"116","author":"Z Sun","year":"2010","unstructured":"Sun Z, Xu Y, Li DM, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based n category for gastric cancer patients with R0 resection. Cancer. 2010;116(11):2571\u201380. \n                    https:\/\/doi.org\/10.1002\/cncr.24989\n                    \n                  .","journal-title":"Cancer"},{"issue":"5","key":"5048_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijsu.2013.03.009","volume":"11","author":"H Liu","year":"2013","unstructured":"Liu H, Deng J, Zhang R, Hao X, Jiao X, Liang H. The RML of lymph node metastasis was superior to the LODDS forevaluating the prognosis of gastric cancer. Int J Surg. 2013;11(5):419\u201324. \n                    https:\/\/doi.org\/10.1016\/j.ijsu.2013.03.009\n                    \n                  .","journal-title":"Int J Surg"},{"issue":"2","key":"5048_CR13","doi-asserted-by":"publisher","first-page":"e31736","DOI":"10.1371\/journal.pone.0031736","volume":"7","author":"Miao-zhen Qiu","year":"2012","unstructured":"Qiu MZ, Qiu HJ, Wang ZQ, et al. The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China. PLoS One. 2012;7(2). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0031736\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"SUPPL. 3","key":"5048_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1245\/s10434-011-1817-x","volume":"18","author":"C Yu","year":"2011","unstructured":"Yu C, Ying Z, Chen W. The impact of calculation procedure on the hazard ratio of N classifications. Ann Surg Oncol. 2011;18(SUPPL. 3):209\u201310. \n                    https:\/\/doi.org\/10.1245\/s10434-011-1817-x\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"5048_CR15","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1007\/s11605-008-0651-3","volume":"12","author":"J Wang","year":"2008","unstructured":"Wang J, Hassett JM, Dayton MT, Kulaylat MN. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg. 2008;12(10):1790\u20136. \n                    https:\/\/doi.org\/10.1007\/s11605-008-0651-3\n                    \n                  .","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"5048_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/jnci\/djk092","volume":"99","author":"GJ Chang","year":"2007","unstructured":"Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433\u201341. \n                    https:\/\/doi.org\/10.1093\/jnci\/djk092\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"5048_CR17","doi-asserted-by":"publisher","first-page":"e28937","DOI":"10.1371\/journal.pone.0028937","volume":"6","author":"Yong-Xi Song","year":"2011","unstructured":"Song YX, Gao P, Wang ZN, et al. Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes? PLoS One. 2011;6(12). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0028937\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"5048_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3892\/mco.2017.1203","volume":"17","author":"H Fang","year":"2017","unstructured":"Fang H, Yang H, He Z, et al. Log odds of positive lymph nodes is superior to the number and ratiobased lymph node classification systems for colorectal cancer patients undergoing curative (R0) resection. Mol Clin Oncol. 2017;17:782\u20138. \n                    https:\/\/doi.org\/10.3892\/mco.2017.1203\n                    \n                  .","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"5048_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1634\/theoncologist.2015-0441","volume":"21","author":"CW Lee","year":"2016","unstructured":"Lee CW, Wilkinson KH, Sheka AC, Leverson GE, Kennedy GD. The log odds of positive lymph nodes stratifies and predicts survival of high-risk individuals among stage III rectal Cancer patients. Oncologist. 2016;21(4):425\u201332. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0441\n                    \n                  .","journal-title":"Oncologist"},{"issue":"11","key":"5048_CR20","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/cncr.25032","volume":"116","author":"JF Chou","year":"2010","unstructured":"Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010;116(11):2560\u201370. \n                    https:\/\/doi.org\/10.1002\/cncr.25032\n                    \n                  .","journal-title":"Cancer"},{"issue":"36","key":"5048_CR21","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1200\/JCO.2009.23.7958","volume":"27","author":"M G\u00f6nen","year":"2009","unstructured":"G\u00f6nen M, Schrag DM, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol. 2009;27(36):6166\u201371. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.23.7958\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"2","key":"5048_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1463-1318.2007.01225.x","volume":"10","author":"MD Evans","year":"2008","unstructured":"Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with dukes\u2019 stage B disease. Color Dis. 2008;10(2):157\u201364. \n                    https:\/\/doi.org\/10.1111\/j.1463-1318.2007.01225.x\n                    \n                  .","journal-title":"Color Dis"},{"issue":"11","key":"5048_CR23","doi-asserted-by":"publisher","first-page":"O386","DOI":"10.1111\/codi.12702","volume":"16","author":"NC Arslan","year":"2014","unstructured":"Arslan NC, Sokmen S, Canda AE, Terzi C, Sarioglu S. The prognostic impact of the log odds of positive lymph nodes in colon cancer. Color Dis. 2014;16(11):O386\u201392. \n                    https:\/\/doi.org\/10.1111\/codi.12702\n                    \n                  .","journal-title":"Color Dis"},{"issue":"3","key":"5048_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00268-011-1415-x","volume":"36","author":"R Persiani","year":"2012","unstructured":"Persiani R, Cananzi FCM, Biondi A, et al. Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system. World J Surg. 2012;36(3):667\u201374. \n                    https:\/\/doi.org\/10.1007\/s00268-011-1415-x\n                    \n                  .","journal-title":"World J Surg"},{"key":"5048_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijsu.2016.06.002","volume":"32","author":"B Huang","year":"2016","unstructured":"Huang B, Chen C, Ni M, Mo S, Cai G, Cai S. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: a retrospective analysis of 17,632 patients in the SEER database. Int J Surg. 2016;32:24\u201330. \n                    https:\/\/doi.org\/10.1016\/j.ijsu.2016.06.002\n                    \n                  .","journal-title":"Int J Surg"},{"key":"5048_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/02841860701203537","volume":"46","author":"D Edler","year":"2007","unstructured":"Edler D, Ohrling K, Hallstrom M, Karlberg M, Ragnhammar P. The number of analyzed lymph nodes a prognostic factor in colorectal cancer. Acta Oncol. 2007;46:975\u201381.","journal-title":"Acta Oncol"},{"key":"5048_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ciresp.2010.09.002","volume":"88","author":"D Mart\u00ednez-Ramos","year":"2010","unstructured":"Mart\u00ednez-Ramos D, Escrig-Sos J, Hoashi JS, Rivadulla-Serrano I, Salvador-Sanch\u00eds JL, Ruiz Del Castillo J. A method for individualising the risk of a negative lymph node classification error in cancer of the colon. Cir Esp. 2010;88:383\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ciresp.2010.09.002\n                    \n                  .","journal-title":"Cir Esp"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5048-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T19:14:54Z","timestamp":1575400494000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5048-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5048-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patients\u2019 right to data confidentiality and privacy were specifically preserved and bioethical approval for the study was obtained from the cancer registry. The study was approved by the institutional review board of the Hospital General de Castellon (PIC: 2013\/2\/CIR).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1208"}}